Clinical Trials Using Padeliporfin

Clinical trials are research studies that involve people. The clinical trials on this list are studying Padeliporfin. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-2 of 2
  • Vascular-Targeted Photodynamic Therapy with Padeliporfin in Treating Dysphagia in Patients with Stage IV Esophageal Cancer

    This phase I trial studies the side effects and best dose of vascular-targeted photodynamic therapy with padeliporfin in treating dysphagia in patients with stage IV esophageal cancer. Padeliporfin is a photosensitizing drug which stays in the blood vessels and becomes active when exposed to light. Vascular-targeted photodynamic therapy uses a laser to activate padeliporfin and may kill tumor cells and improve swallowing in patients with esophageal cancer.
    Location: Memorial Sloan Kettering Cancer Center, New York, New York

  • Padeliporfin Phototherapy in Treating Patients with Recurrent Ureter and / or Renal Pelvis Urothelial Cancer

    This phase I trial studies the best dose and side effect of laser light fluence rate, and how well it works with padeliporfin in treating patients with ureter and / or renal pelvis urothelial cancer that has come back. Phototherapy uses a drug, such as padeliporfin, that becomes active when it is exposed to light. The activated drug may kill tumor cells in patients with ureter and / or renal pelvis urothelial cancer.
    Location: Memorial Sloan Kettering Cancer Center, New York, New York